BioQuest (BQST) Stock Statistics & Valuation Metrics
Total Valuation
BioQuest has a market cap or net worth of $7.47M. The enterprise value is $1.14T.
- Market Cap
- $7.47M
- Enterprise Value
- $1.14T
Share Statistics
BioQuest has 29,895,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 29,895,230
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
BioQuest’s return on equity (ROE) is 0.82 and return on invested capital (ROIC) is 135.23%.
- Return on Equity (ROE)
- 0.82
- Return on Assets (ROA)
- -547.85
- Return on Invested Capital (ROIC)
- 135.23%
- Return on Capital Employed (ROCE)
- 0.84
- Revenue Per Employee
- 44.64K
- Profits Per Employee
- -226.26K
- Employee Count
- 4
- Asset Turnover
- 108.09
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of BioQuest is -8.74. BioQuest’s PEG ratio is -0.39.
- PE Ratio
- -8.74
- PS Ratio
- 40.52
- PB Ratio
- -0.66
- Price to FCF
- -26.63
- Price to Operating Cash Flow
- -2.66
- PEG Ratio
- -0.39
Income Statement
In the last 12 months, BioQuest had revenue of 178.56K and earned -905.05K in profits. Earnings per share was -0.03.
- Revenue
- 178.56K
- Gross Profit
- 69.04K
- Operating Income
- -838.05K
- Pretax Income
- -905.05K
- Net Income
- -905.05K
- EBITDA
- -838.05K
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -280.69K and capital expenditures 3, giving a free cash flow of -280.69K billion.
- Operating Cash Flow
- -280.69K
- Free Cash Flow
- -280.69K
- Free Cash Flow per Share
- -0.09
Dividends & Yields
BioQuest pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.76%
- Earnings Yield
- -89.35%
Stock Price Statistics
- Beta
- 1.81
- 52-Week Price Change
- -75.00%
- 50-Day Moving Average
- 0.36
- 200-Day Moving Average
- 0.31
- Relative Strength Index (RSI)
- 50.92
- Average Volume (3m)
- 17.14K
Financial Position
BioQuest as a current ratio of 0.00, with Debt / Equity ratio of -34.77%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- -0.46
- Interest Coverage Ratio
- -12.51
Taxes
In the past 12 months, BioQuest has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
BioQuest EV to EBITDA ratio is -13.22, with an EV/FCF ratio of -28.00.
- EV to Sales
- 42.60
- EV to EBITDA
- -13.22
- EV to Free Cash Flow
- -28.00
- EV to Operating Cash Flow
- -28.00
Balance Sheet
BioQuest has $3,807.00 in cash and marketable securities with $388.39K in debt, giving a net cash position of -$384.59K billion.
- Cash & Marketable Securities
- $3,807.00
- Total Debt
- $388.39K
- Net Cash
- -$384.59K
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- -$0.38
Margins
Gross margin is 112.96%, with operating margin of -325.82%, and net profit margin of -361.51%.
- Gross Margin
- 112.96%
- Operating Margin
- -325.82%
- Pretax Margin
- -361.51%
- Net Profit Margin
- -361.51%
- EBITDA Margin
- -322.33%
- EBIT Margin
- -322.33%
Analyst Forecast
The average price target for BioQuest is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 13.10%
- EPS Growth Forecast
- 30.07%
